Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli
- PMID: 24805362
- PMCID: PMC4013016
- DOI: 10.1371/journal.pone.0096659
Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli
Abstract
Objective: Female genital tract secretions inhibit E. coli ex vivo and the activity may prevent colonization and provide a biomarker of a healthy microbiome. We hypothesized that high E. coli inhibitory activity would be associated with a Lactobacillus crispatus and/or jensenii dominant microbiome and differ from that of women with low inhibitory activity.
Study design: Vaginal swab cell pellets from 20 samples previously obtained in a cross-sectional study of near-term pregnant and non-pregnant healthy women were selected based on having high (>90% inhibition) or low (<20% inhibition) anti-E. coli activity. The V6 region of the 16S ribosomal RNA gene was amplified and sequenced using the Illumina HiSeq 2000 platform. Filtered culture supernatants from Lactobacillus crispatus, Lactobacillus iners, and Gardnerella vaginalis were also assayed for E. coli inhibitory activity.
Results: Sixteen samples (10 with high and 6 with low activity) yielded evaluable microbiome data. There was no difference in the predominant microbiome species in pregnant compared to non-pregnant women (n = 8 each). However, there were significant differences between women with high compared to low E. coli inhibitory activity. High activity was associated with a predominance of L. crispatus (p<0.007) and culture supernatants from L. crispatus exhibited greater E. coli inhibitory activity compared to supernatants obtained from L. iners or G. vaginalis. Notably, the E. coli inhibitory activity varied among different strains of L. crispatus.
Conclusion: Microbiome communities with abundant L. crispatus likely contribute to the E. coli inhibitory activity of vaginal secretions and efforts to promote this environment may prevent E. coli colonization and related sequelae including preterm birth.
Conflict of interest statement
Figures
References
-
- National Center for Health Statistics from the http://www.marchofdimes.com/peristats. Accessed: 2013 January 24.
-
- National Center for Health Statistics from http://www.marchofdimes.com/peristats. Accessed: 2013 January 24.
-
- Carey JC, Klebanoff MA (2005) Is a change in the vaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol 192: 1341–1346 discussion 1346–1347. - PubMed
-
- Lin CY, Hsu CH, Huang FY, Chang JH, Hung HY, et al. (2011) The changing face of early-onset neonatal sepsis after the implementation of a maternal group B Streptococcus screening and intrapartum prophylaxis policy–a study in one medical center. Pediatr Neonatol 52: 78–84. - PubMed
Publication types
MeSH terms
Grants and funding
- AI072204/AI/NIAID NIH HHS/United States
- KL2 RR025749/RR/NCRR NIH HHS/United States
- UL1 RR025750/RR/NCRR NIH HHS/United States
- R33 AI079763/AI/NIAID NIH HHS/United States
- ULI RR025750/RR/NCRR NIH HHS/United States
- R01 AI092743/AI/NIAID NIH HHS/United States
- R01 CA078527/CA/NCI NIH HHS/United States
- UL1 TR001073/TR/NCATS NIH HHS/United States
- R01 AI072204/AI/NIAID NIH HHS/United States
- U01 CA078527/CA/NCI NIH HHS/United States
- AI065309/AI/NIAID NIH HHS/United States
- P30CA013330/CA/NCI NIH HHS/United States
- AI079763/AI/NIAID NIH HHS/United States
- R56 AI072204/AI/NIAID NIH HHS/United States
- CA78527/CA/NCI NIH HHS/United States
- P30 CA013330/CA/NCI NIH HHS/United States
- R21 AI079763/AI/NIAID NIH HHS/United States
- R01 AI065309/AI/NIAID NIH HHS/United States
- KL2RR025749/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
